Formation of indenesulfonylureas in the metabolism of the anticancer agent sulofenur in rats, monkeys, and humans
Ehlhardt, W.J.; Zimmermann, J.L.; Ray, J.E.; Toth, J.E.
Drug Metabolism and Disposition the Biological Fate of Chemicals 20(6): 958-961
1992
ISSN/ISBN: 0090-9556 PMID: 1362953 Document Number: 387954
Document emailed within 1 workday
Related Documents
Lindstrom, T.D.; Lacefield, W.B.; Whitaker, G.W. 1984: Metabolism of the antiarrhythmic agent, indecainide, in rats, dogs, and monkeys Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(6): 691-697Nicolas, F.; De Sousa, G.; Thomas, P.; Placidi, M.; Lorenzon, G.; Rahmani, R. 1995: Comparative metabolism of 3'-azido-3'-deoxythymidine in cultured hepatocytes from rats, dogs, monkeys, and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(3): 308-313
Schrier, A.M.; Angarella, R.; Povar, M.L. 1984: Studies of concept formation by stumptailed monkeys concepts humans monkeys and letter a Journal of Experimental Psychology Animal Behavior Processes 10(4): 564-584
Martin, S.W.; Bishop, F.E.; Kerr, B.M.; Moor, M.; Moore, M.; Sheffels, P.; Rashed, M.; Slatter, J.G.; Berthon-Cédille, L.; Lepage, F.; Descombe, J.J.; Picard, M.; Baillie, T.A.; Levy, R.H. 1997: Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(1): 40-46
Dockens, R.C.; Santone, K.S.; Mitroka, J.G.; Morrison, R.A.; Jemal, M.; Greene, D.S.; Barbhaiya, R.H. 2000: Disposition of radiolabeled ifetroban in rats, dogs, monkeys, and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(8): 973-980
Kobayashi, S.; Sakai, T.; Dalrymple, P.D.; Wood, S.G.; Chasseaud, L.F. 1993: Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs Arzneimittel-Forschung 43(12): 1367-1377
Maeshiba, Y.; Kiyota, Y.; Yamashita, K.; Yoshimura, Y.; Motohashi, M.; Tanayama, S. 1997: Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys Arzneimittel-Forschung 47(1): 29-35
Ruterbories, K.J.; Lindstrom, T.D. 1990: Pharmacokinetics of a novel butylated hydroxytoluene-thiazolidinone CNS antiischemic agent LY256548 in rats, mice, dogs, and monkeys Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(5): 674-679
Kato, M.; Furuhama, K.; Woolley, A.P.; Ashby, R.; Fowler, J.S.; Takayama, S. 1992: Twenty-six-week oral toxicity of the new quinolone antibacterial agent levofloxacin in rats and cynomolgus monkeys Arzneimittel-Forschung 43(3a): 367-373
Emary, W.B.; Toren, P.C.; Mathews, B.; Huh, K. 1998: Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(8): 725-731
Yount, D.E. 1979: Application of a bubble formation model to decompression sickness in rats and humans Aviation Space and Environmental Medicine 50(1): 44-50
Huskey, S.E.; Miller, R.R.; Chiu, S.H. 1993: N-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(5): 792-799
Teunissen, M.W.; De Leede, L.G.; Boeijinga, J.K.; Breimer, D.D. 1985: Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state Journal of Pharmacology and Experimental Therapeutics 233(3): 770-775
Pessayre, D. 1983: Effects of macrolide antibiotics on drug metabolism in rats and in humans International Journal of Clinical Pharmacology Research 3(6): 449-458
Guttmann, A.; Nagy, J.; Magyar, K. 1987: The metabolism of EGYT-475, a new antidepressant agent, in rats Polish Journal of Pharmacology and Pharmacy 39(2): 123-128
Sugawara, T.; Yoshida, M.; Shimoda, K.; Takada, S.; Miyamoto, M.; Nomura, M.; Kato, M. 1996: One-month oral toxicity study of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)-9-fluoro-2,3-dihydro-3- methyl-7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid hemihydrate in rats and cynomolgus monkeys Arzneimittel-Forschung 46(7): 705-710
Hashimoto, M.; Miyazaki, H.; Nambu, K.; Fujii, T.; Arakawa, S.; Yoshida, K.; Utsui, Y. 1979: Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. II. Urinary metabolites Drug Metabolism and Disposition: the Biological Fate of Chemicals 7(1): 20-23
Siefert, H.M.; Maruhn, D.; Maul, W.; Förster, D.; Ritter, W. 1986: Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys Arzneimittel-Forschung 36(10): 1496-1502
French, T.J.; Goode, A.W.; Holness, M.J.; Sugden, M.C. 1985: Carnitine metabolism in livers and hearts of 48h-starved rats: the contribution of fat and carbohydrate to acylcarnitine formation Biochemistry International 11(2): 265-272
Zhang, H.; Jiang, X.; Song, W.; Yang, Z. 2019: Review-Novel synthetic curcuminoids: not merely an anticancer agent Pakistan Journal of Pharmaceutical Sciences 32(4): 1723-1747